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Lupus low disease activity state is associated with lower adjusted mean SLEDAI and less lupus  
renal and haematological involvement
LH Lee, MY Mok, C Cheung, KY Yuen, HY Chung, WL Li, E Au, HL Tsang, WS Wong, J Hui, Y Lo, CS Lau 
Division of Rheumatology and Clinical Immunology, The University of Hong Kong, Hong Kong
Introduction: There is currently no agreed definition of a ‘safe’ state of systemic lupus erythematosus (SLE) 
despite the availability of various validated scales on its disease activity and damage. In 2013, the Asia Pacific 
Lupus Collaboration presented a definition of low disease activity of this condition, the Lupus Low Disease 
Activity State (LLDAS), which is conceptualised as “a state which, if sustained, is associated with a low likelihood 
of adverse outcome” and defined as:
1. SLE Disease activity Index (SLEDAI-2k) ≤4, with no SLEDAI activity in major organ systems (renal, central 
nervous system, cardiopulmonary, vasculitis, haemolytic anaemia, fever) and no gastro-intestinal activity; 
2. No new features of lupus disease activity compared to the previous assessment; 
3. SELENA-SLEDAI physician global assessment (Physician Global Assessment, scale 0-3) ≤1; 
4. Current prednisolone (or equivalent) dose ≤7.5 mg daily; and 
5. Well-tolerated standard maintenance doses of immunosuppressive drugs and / or approved biologic agents.
This study was a preliminary analysis of a LLDAS cohort validation study which examines prospectively whether 
sustained LLDAS is associated with lower disease activity, damage, and mortality. 
Methods: A cross-sectional study was carried out to determine the frequency of and the factors associated with 
LLDAS. Consecutive patients with SLE as defined by the revised American College of Rheumatology criteria 
seen at the Queen Mary Hospital during the period August 2013 to October 2013 were enrolled in the study. 
SLEDAI scores and their components, and lupus organ manifestations between patients who achieved LLDAS 
or not were compared using a Wilcoxon rank-sum test. 
Results: Of the 201 patients recruited, patients who achieved LLDAS had a significantly lower mean adjusted 
mean SLEDAI score (2.40 ± 2.33) over the past 4 years when compared with patients who failed to achieve LLDAS 
(adjusted mean SLEDAI = 3.86 ± 2.17; P<0.000005). Similarly, patients who achieved LLDAS had lower anti-dsDNA 
and higher complement levels (P = 0.0012), and lower renal (P = 0.0028) and haematological (P = 0.011) scores. 
Conclusion: Preliminary analysis shows that LLDAS can discriminate patients with a relatively safe course of 
disease, as reflected by the association of LLDAS with lower adjusted mean SLEDAI for the past 4 years and less 
renal and haematological involvement. Further follow-up prospective studies may reveal whether a sustained 
LLDAS is associated with a better prognosis with less cumulative disease activity, damage, and lower mortality 
rate.
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Introduction: Obstructive sleep apnoea is characterised by repetitive episodes of complete or partial upper 
airway collapse during sleep, leading to recurrent drop in arterial oxygenation (intermittent hypoxia [IH]) and 
sleep fragmentation. Repetitive IH with rapid reversal to normoxia initiates a series of pathological events 
such as oxidative stress, inflammation, and sympathetic activation, all of which contributes to endothelial 
dysfunction (a predictor and precursor of atherosclerosis). The aim of the current study was to investigate the 
effect of IH on the activation of endothelial cells in a cellular model in vitro. 
Methods: Cultured endothelial EA.hy926 cells were exposed to IH in the hypoxic chamber in which the O2 levels 
were alternated between 1% for 10 minutes and 21% for 5 minutes. Cells in the control group were maintained 
in normoxic conditions (IN: 21% and 5% CO2). Cells were exposed to IN or IH for 64 cycles. Expression of 
protein of interests in endothelial cells was analysed by Western blotting.
Results: Endothelial nitric oxide synthase (eNOS), a key enzyme regulating endothelial function, was 
downregulated after exposure to IH while inflammatory response proteins such as cyclooxygenase–2 and 
inducible NOS (iNOS) were upregulated. Increased phosphorylation of Akt [p-Akt (ser473)], Erk (p-Erk1/2), and 
p38 (p-p38) was observed in IH-treated cells compared to the control cells. 
Conclusion: IH induces endothelial dysfunction with reduced eNOS protein expression. The expression of 
inflammatory proteins and activation of the specific signalling pathways suggest pathophysiological changes in 
response to IH in this in-vitro cellular model.
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